Blood clot risk after abdominoplasty: what surgery and travel evidence can tell us

A blood clot is a feared complication after abdominoplasty (tummy tuck), but the evidence does not support a single risk figure or prevention plan for everyone. Studies differ in who was included, how clots were detected, which operations were grouped together and whether patients received preventive anticoagulants. A long journey adds another period of restricted movement; it is a separate question from whether someone is recovering safely from surgery.

This review explains the distinction between deep vein thrombosis and pulmonary embolism, summarises the available abdominoplasty evidence, and sets out practical questions to discuss with the treating team. It does not estimate an individual’s risk, prescribe medication or establish when a person can fly.

What a post-operative blood clot means

Venous thromboembolism (VTE) is the collective term for a clot in a deep vein (deep vein thrombosis, or DVT) and a clot that travels to the lungs (pulmonary embolism, or PE). A DVT often forms in a leg. Part of a clot can break away and travel through the bloodstream to the lungs, where a PE can be life-threatening. Symptoms are not always obvious, so the absence of a visible symptom cannot be used to rule out a clot. [6]

Bleeding and a wound haematoma are different outcomes. Anticoagulant medicines can be considered to lower clot risk in some circumstances, but they can also increase bleeding risk. A study finding no statistically significant difference between groups does not establish that a medicine has no effect or that it is safe for every patient. [2]

Why risk varies between patients and operations

Risk is shaped by more than the procedure name. Personal and clinical factors, the extent and duration of surgery, associated procedures, recovery and mobility all matter. Abdominoplasty may include tightening the abdominal fascia (often called plication); some studies have examined whether this changes clot risk, but their results conflict.

In a retrospective series of 1,370 consecutive operations by one surgeon, the final publisher article reported VTE frequencies of 2.3% with plication and 0.36% without it. The group event totals do not reconcile with related commentary, so these figures should be read cautiously. Events within 90 days after surgery were confirmed by lower-extremity duplex ultrasound and/or CT pulmonary angiography. The observational design cannot establish causation or predict personal risk. The proposed score adjustment is not a universally validated clinical rule. The author proposes that abdominal wall tightening may raise intra-abdominal pressure and affect venous return; this is a possible mechanism, not a proven causal pathway. [1]

An earlier systematic review of 30 studies, drawn from 114 articles reviewed, grouped abdominal contouring operations by procedure. It reported VTE frequencies of 0.35% after abdominoplasty alone, 0.79% when combined with another plastic surgery procedure, 2.17% when combined with an intra-abdominal procedure and 3.40% after circumferential abdominoplasty. The review found higher frequencies in the latter groups, but the underlying studies were heterogeneous and the estimates reflect older published evidence. They should not be treated as current personal probabilities. [4]

What risk scores can and cannot do

Risk assessment models, including the Caprini score, organise recognised risk factors to support a clinician’s assessment. A systematic review and meta-analysis of eight plastic-surgery studies covering 1,348,606 patients found higher observed VTE odds in higher Caprini categories. For the super-high category, reported odds were higher than in high-risk patients (odds ratio 2.92; 95% confidence interval 1.26–6.78), medium-risk patients (5.29; 2.38–11.79) and low-risk patients (10.00; 2.32–43.10). [5]

That evidence concerns mixed plastic-surgery populations and risk prediction; it does not prove that a score-guided prevention strategy improves outcomes specifically after abdominoplasty. Studies use different cut-offs, follow-up periods and outcome definitions. A score is one input to a clinical discussion, not a diagnosis, a guarantee or a substitute for a surgeon’s individual assessment.

Clot prevention and bleeding: what the studies found

A PRISMA systematic review pooled ten observational articles involving 1,596 abdominoplasty patients. Of these, 691 received some form of chemoprophylaxis and 905 did not; 96.8% were women and 73% had concomitant liposuction. The authors reported VTE in 9 of 1,596 patients (0.56%) and bleeding in 25 of 1,596 (1.6%). In comparisons with and without chemoprophylaxis, bleeding was 1.3% (9/671) versus 0.91% (8/881; P=0.417), while VTE was 0.87% (6/691) versus 0.33% (3/901; P=0.187). Neither comparison was statistically significant. [2]

The review noted that patients were not clearly risk-stratified and that reporting was inconsistent. Its abstract gives a no-prophylaxis cohort of 905, while the outcome denominators are 881 for bleeding and 901 for VTE; the abstract does not explain those differences. The results therefore cannot show that prophylaxis is ineffective, unnecessary or equivalent to no prophylaxis. Nor can they settle the balance of clot prevention and bleeding for a particular patient.

A separate retrospective study at one university plastic-surgery unit reviewed 219 patients. Everyone actually received low-molecular-weight heparin (LMWH), for a mean of 14.9 ± 1.5 days. One patient (0.45%) developed PE and 13 (5.9%) developed haematoma. The reported 44.5% reduction was a modelled reduction in LMWH expenditure under a proposed Caprini-based approach, not an observed reduction in complications. Because there was no untreated comparison group, this study cannot establish that the modelled strategy would prevent the same number of clots or bleeding events in practice. [3]

Taken together, the studies describe uncertainty rather than a universal prescription. Decisions about mechanical measures, medicines, timing and duration belong to the clinician responsible for the operation and should account for both clot and bleeding concerns. Do not start, stop or change an anticoagulant or aspirin on the basis of this article.

Air travel adds prolonged sitting

Travel is a further exposure to restricted movement. The US Centers for Disease Control and Prevention (CDC) says journeys lasting more than four hours by air, car, bus or train can increase the chance of a travel-related clot; sitting still for long periods is one mechanism. Its general travel guidance identifies recent surgery (within three months) and limited mobility among relevant risk factors. These are general travel observations, not research establishing a safe time to fly after abdominoplasty. [6]

Being able to stand or take a short walk soon after surgery does not establish fitness for a long-haul flight, complete wound healing or readiness to return to work. The studies cited here do not define a universal post-operative day when flying becomes safe. Ask the treating surgical team for an individual assessment that considers the operation performed, your recovery, mobility, clot and bleeding risks, and the practical arrangements for care during and after travel. A package or travel itinerary cannot determine medical fitness to fly.

The extent of surgery and any associated procedures are among the issues to discuss when reviewing clinical risk and budgeting; our tummy tuck cost guide for Turkey provides commercial price context, not an estimate of personal care needs.

Questions to discuss with the treating team

When reviewing recovery logistics described by a provider, the tummy tuck package details are commercial information only. They do not establish suitable follow-up, prevention measures or travel arrangements for an individual.

• Which factors in my medical history and planned operation affect my clot and bleeding risks?
• How will my risk be assessed, and what are the limits of the score or protocol being used?
• What prevention measures are planned, why are they appropriate for me, and what warning signs or bleeding concerns should I know about?
• How will mobility and follow-up be managed after discharge?
• Given my operation and recovery, when should I seek an individual travel assessment?

Seek urgent medical assessment for possible DVT or PE symptoms, such as new one-sided leg swelling or pain, sudden breathlessness, chest pain, fainting or coughing blood. These symptoms can have other causes, but they should not be assessed through a website article.

What this evidence cannot establish

Most procedure-specific findings come from retrospective cohorts or reviews of observational studies, which are vulnerable to confounding and inconsistent outcome reporting. The studies do not provide a single contemporary estimate that applies to every patient, prove that one prophylaxis approach is best, or set a postoperative flight-clearance date. Travel guidance addresses travel-related immobility generally, not recovery after abdominoplasty. Clinical decisions require an appropriately qualified treating professional with access to the individual’s history and current condition.

Just Clinic Istanbul is an independent marketing and lead-generation platform, not a healthcare provider or medical tourism intermediary. Enquiries may be shared with authorised healthcare partners with your consent.

References

1. Restifo RJ. An In-Depth Analysis of 1370 Consecutive Abdominoplasties: Fascial Plication Increases Risk of Venous Thromboembolism, and Scoring for Plication Improves the Caprini Risk Assessment Model. Aesthetic Surgery Journal. 2024;44(12):NP870–NP882. Online 5 July 2024. doi: 10.1093/asj/sjae139. PMID: 38967610.
2. Perzia BM, Marquez J, Mellia JA, et al. Venous Thromboembolism and Bleeding Events With Chemoprophylaxis in Abdominoplasty: A Systematic Review and Pooled Analysis of 1596 Patients. Aesthetic Surgery Journal. 2021;41(11):1279–1289. Online 18 February 2021. doi: 10.1093/asj/sjab090. PMID: 33599713.
3. Asiry A, Sayegh A, Gangloff D, et al. Utility of the Caprini risk assessment model in guiding venous thromboembolism prophylaxis after abdominoplasty. JPRAS Open. 2025;46:305–315. Published online 17 September 2025. doi: 10.1016/j.jpra.2025.09.017. PMID: 41215826. Corrigendum: 2026;48:711, doi: 10.1016/j.jpra.2026.01.001; affiliation information corrected.
4. Hatef DA, Trussler AP, Kenkel JM. Procedural risk for venous thromboembolism in abdominal contouring surgery: a systematic review of the literature. Plastic and Reconstructive Surgery. 2010;125(1):352–362. doi: 10.1097/PRS.0b013e3181c2a3b4. PMID: 20048626.
5. Mrad MA, Al Qurashi AA, Shah Mardan QNM, Al Ghamdi AA, Al Jabr FA, Almenhali AA, AlMansour A, Al Maghrabi A, Allhybi AK, Merdad RH, Abdulqader Alaa'adeen. Venous Thromboembolism Risk Assessment Models in Plastic Surgery: A Systematic Review and Meta-Analysis. Plastic and Reconstructive Surgery Global Open. 2022;10(12):e4683. doi: 10.1097/GOX.0000000000004683. PMID: 36518690; PMCID: PMC9742083.
6. Centers for Disease Control and Prevention. Understanding Your Risk for Blood Clots with Travel. 15 May 2024. CDC guidance.